Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 19.59B 2.88B 2.52B 2.33B 2.16B 4.1B 275B 4.15B 27.84B 10.83B 135B 10.83B 10.59B 468B P/E 2026 *
13.2x
P/E 2027 * 11.5x
Enterprise Value 16.07B 2.37B 2.07B 1.91B 1.77B 3.36B 226B 3.41B 22.84B 8.89B 111B 8.88B 8.69B 384B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.47x
Free-Float
34.77%
Yield 2026 *
5.24%
Yield 2027 * 5.53%
1 day+0.88%
1 week+11.11%
Current month+14.44%
1 month+7.97%
3 months-3.53%
6 months-4.66%
Current year-2.38%
1 week 14.81
Extreme 14.81
17.28
1 month 14.39
Extreme 14.39
17.4
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
30.22
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.0028
61.63
Manager TitleAgeSince
Chief Executive Officer 44 27/02/2019
Director of Finance/CFO 44 09/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 63 07/08/2016
Chairman 59 15/07/2013
Chairman 48 27/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%+11.11%+2.56%-36.25% 2.86B
+1.58%+3.98%-16.12%-5.34% 5.87B
+0.60%+6.36%-19.65%-32.82% 3.57B
-1.84%+2.14%-36.77%-8.42% 3.44B
-0.21%+0.59%-27.73%-45.78% 3.26B
-1.48%+2.32%+98.47% - 2.66B
+2.45%+1.38%-16.36%-2.00% 2.46B
-0.18%-4.93%+0.34%+40.59% 1.72B
-1.62%+2.57%-26.98%-33.38% 1.64B
+0.78%+0.26%+60.16%+108.74% 1.16B
Average +0.08%+3.67%+1.79%-1.63% 2.86B
Weighted average by Cap. +0.20%+3.96%-4.40%-11.31%

Financials

2026 *2027 *
Net sales 29.97B 4.41B 3.86B 3.56B 3.3B 6.27B 421B 6.36B 42.59B 16.58B 207B 16.56B 16.2B 716B 33.2B 4.89B 4.28B 3.94B 3.66B 6.95B 466B 7.04B 47.19B 18.36B 229B 18.35B 17.95B 793B
Net income 1.48B 219M 191M 176M 164M 311M 20.84B 315M 2.11B 821M 10.23B 821M 803M 35.47B 1.7B 251M 219M 202M 188M 356M 23.9B 361M 2.42B 941M 11.73B 941M 920M 40.67B
Net Debt -3.52B -518M -454M -418M -388M -736M -49.41B -746M -5B -1.95B -24.25B -1.95B -1.9B -84.08B -4.01B -590M -517M -476M -442M -839M -56.29B -850M -5.7B -2.22B -27.63B -2.22B -2.17B -95.8B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
06/07/26 CN¥17.20 +0.88% 8,223,188
03/07/26 CN¥17.05 +4.67% 9,861,832
02/07/26 CN¥16.29 +0.87% 8,726,474
01/07/26 CN¥16.15 +7.45% 13,120,235
30/06/26 CN¥15.03 -2.91% 6,234,096
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
17.20CNY
Average target price
24.49CNY
Spread / Average Target
+42.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock